Omniscient

Omniscient

Private
Sydney, New South WalesHealthcare & Life Scienceshttps://www.o8t.com

Last Round

Series D

May 29, 2026

Total Funding Raised

$134.35M

Company Overview

Omniscient is a healthcare technology company that offers a cloud-based connectomic analysis platform utilizing artificial intelligence to transform standard MRI scans into detailed brain network maps, facilitating the identification of neurological connections for improved patient care and predictive analytics.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Precision Medicine, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

connectomicsbrain mappingneurosurgical planningFDA-cleared softwareconnectomic analysismedical imaging analysissurgical planning softwarebrain network mappingAI medical imagingneurotechbrain digital twinMRI analysis softwaremedical device softwareneurotechnologyCPT codeB2B healthcare SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Omniscient Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Omniscient Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DMay 29, 2026
Pre SeedApr 3, 2026
Series CJun 11, 2024
Series BJul 19, 2021
Series AJan 1, 2020

Key People

Founding team and executive leadership

Michael Sughrue

Founder And CMO

Founding Team

Stephen Scheeler

CEO

Executive Team

Bryan Sin

Chief Product Officer

Executive Team

Omniscient Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 29, 2026

    $13.3M round completed.

  • Apr 15, 2026

    Neurological planning and visualization tool using resting-state fMRI has received FDA clearance.

Omniscient Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Omniscient Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Omniscient's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney, New South Wales
Employee Range60
Year Founded2004
Last FundingMay 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.